Grand River Aseptic Manufacturing
140 Front Avenue SW
Suite 3
Grand Rapids
Michigan
49504
United States
Tel: 616-678-2400
Website: http://www.grandriverasepticmfg.com/
About Grand River Aseptic Manufacturing
Grand River Aseptic Manufacturing was founded in 2010 as a joint venture between the Van Andel Institute and Grand Valley State University. Our company supports the life sciences industry’s growing need for high-quality, outsourced sterile parenteral manufacturing.
YEAR FOUNDED:
2010
LEADERSHIP:
CEO: Thomas J. Ross
12 articles about Grand River Aseptic Manufacturing
-
GRAM Makes Major Investment in Additional Advanced Equipment to Meet Continued Demand
1/26/2021
Bausch+Ströbel vial filler with SKAN Isolator technology, and VarioSys® syringe and vial filler set to arrive in early 2022
-
Grand River Aseptic Manufacturing (GRAM) inked a deal with Janssen Pharmaceutical, a Johnson & Johnson company, to support the manufacturing of Janssen’s COVID-19 vaccine candidate.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 25, 2020.
-
Grand River Aseptic Manufacturing Ranked on the Inc. 5000 List for Fourth Consecutive Year
8/13/2020
Grand River Aseptic Manufacturing, a leading parenteral contract development and manufacturing organization, was recognized in Inc. Magazine's Inc. 5000 list for the fourth consecutive year.
-
Federal Government Selects Grand River Aseptic Manufacturing to Help Combat COVID-19
8/6/2020
HHS and Dept. of Defense call upon the U.S.-based CDMO to expand domestic fill/finish capacity under Operation Warp Speed.
-
Grand River Aseptic Manufacturing Continues Growth, Announces New VP of Business Development
10/28/2019
David joins GRAM as the Vice President of Business Development.
-
Grand River Aseptic Manufacturing Ranked on the Inc. 5000 List for Third Consecutive Year
8/22/2019
Evaluated according to the percentage growth of annual revenue over a three-year period, this global and national recognition celebrates GRAM's superior business productivity, rapid revenue growth and ongoing customer-base expansion.
-
Grand River Aseptic Manufacturing, Inc. Implements Fully-Automated Serialization and Aggregation Solutions Ahead of 2023 DSCSA Deadline
4/30/2019
Grand River Aseptic Manufacturing, Inc., a leading parenteral contract development and manufacturing organization, has implemented its fully-automated serialization and aggregation processes for commercial injectable drug products.
-
Grand River Aseptic Manufacturing, Inc. Expands Pharmaceutical Manufacturing Capacity with Major Equipment Purchase
4/24/2018
Grand River Aseptic Manufacturing, Inc. (GRAM) has announced its second major equipment purchase this year: a state-of-the-art Bausch+Ströbel fully integrated high-speed filling line with SKAN isolator.
-
Grand River Aseptic Manufacturing Continues to Expand Capabilities with New, State-of-the-Art Colanar Syringe Filler
3/6/2018
The Colanar FSV syringe filler will utilize the existing single-use systems already in place at GRAM and will support both small molecule APIs and biologics projects.
-
Arlington Capital Partners Announces Majority Investment in Grand River Aseptic Manufacturing
11/14/2017
Based in Grand Rapids, MI, GRAM is a leading contract, development and manufacturing organization (“CDMO”) focused on the development, manufacture and finishing of parenteral pharmaceuticals.
-
Grand River Aseptic Manufacturing Sponsoring Grand Rapids .1K to End Duchenne
10/31/2017
Proceeds from the 100-meter race on Nov. 4 will be donated to Parent Project Muscular Dystrophy (PPMD), the largest U.S. nonprofit organization focused on ending Duchenne muscular dystrophy.